Mackenzie Financial
RVMD icon

Mackenzie Financial’s Revolution Medicines RVMD Stock Holding History

Mackenzie Financial’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42M Buy
+14,578
New +$1.47M ﹤0.01% 1015
2025
Q3 		– Sell
-10,961
Closed -$403K – 1822
2025
Q2 		$403K Buy
10,961
+2,640
+32% +$101K ﹤0.01% 1297
2025
Q1 		$294K Buy
8,321
+2,266
+37% +$92K ﹤0.01% 1384
2024
Q4 		$265K Buy
6,055
+885
+17% +$44.7K ﹤0.01% 1435
2024
Q3 		$234K Buy
+5,170
New +$225K ﹤0.01% 1301
2024
Q2 		– Sell
-8,932
Closed -$288K – 1613
2024
Q1 		$288K Buy
8,932
+280
+3% +$8.3K ﹤0.01% 1193
2023
Q4 		$248K Buy
+8,652
New +$208K ﹤0.01% 1238

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mackenzie Financial's RVMD Position: Q1 2026 in Review

Mackenzie Financial opened a new position in Revolution Medicines (RVMD) in Q1 2026: 14,578 shares worth $1.42M. The stake represents ﹤0.01% of the portfolio and ranks #1015 among its holdings. This is a return to the name: Mackenzie Financial previously reported a position in RVMD as recently as Q2 2025.

Mackenzie Financial first reported a position in RVMD in Q4 2023 and has held it in 7 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Mackenzie Financial held 14,578 shares of Revolution Medicines worth $1.42M as of Q1 2026.
  • Revolution Medicines was a new Mackenzie Financial position in Q1 2026.
  • Revolution Medicines made up ﹤0.01% of Mackenzie Financial's portfolio in Q1 2026, its #1015 holding.
  • Mackenzie Financial first reported a position in Revolution Medicines in Q4 2023 and has held it in 7 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.